Conatus Pharmaceuticals Inc. To Ring The NASDAQ Stock Market Opening Bell In Celebration Of 2013 Milestones
Published: Dec 18, 2013
SAN DIEGO, Dec. 18, 2013 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, will ring the Opening Bell at the NASDAQ MarketSite in New York today in honor of Conatus' successful initial public offering (IPO) in July 2013 and subsequent advancement of its lead development program.
Help employers find you! Check out all the jobs and post your resume.